Literature DB >> 32884506

Endogenous Heparin-Like Substances May Cause Coagulopathy in a Patient with Severe Postpartum Hemorrhage.

Shichun Wang1, Chao Qi1, Zhicheng Liu1, Ting Xu1, Chunyan Yao1.   

Abstract

INTRODUCTION: Postpartum hemorrhage (PPH) is associated with maternal morbidity and mortality. Accurate diagnosis of the cause of puerperal hemorrhage is as important as treatment strategies for resuscitation. We report a case of coagulation disorder caused by endogenous heparin-like substances in a PPH patient. CASE
PRESENTATION: A 30-year-old woman with no medical history of bleeding disorders suffered intractable hemorrhage following spontaneous delivery in a local hospital. The patient was transferred to the department of obstetrics of a superior hospital. On arrival, the patient was found to have severe hemorrhagic anemia, hemorrhagic shock, and disseminated intravascular coagulation. Active treatments were performed, but the patient continued bleeding. Laboratory testing, performed during early treatment, revealed that all coagulation factors were below normal. The differences between CK-TEG R-time (reaction time in citrated kaolin thromboelastography assay) and CKH-TEG R-time (reaction time in citrated kaolin with heparinase thromboelastography assay) suggested the presence of heparin activity. However, the patient's family denied heparin use prior to presentation. Thus, we deduced that endogenous heparin-like substances were the main cause of the coagulopathy. After receiving treatment with protamine, the patient stopped bleeding. Meanwhile, all coagulation parameters and the TEG assay results improved.
CONCLUSIONS: In this case report, TEG assay suggested the presence of heparin activity in a PPH patient, and treatment also highlighted the importance of analyzing different parameters in TEG.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Coagulopathy; Disseminated intravascular coagulation; Endogenous heparin; Postpartum hemorrhage; Thromboelastography

Year:  2019        PMID: 32884506      PMCID: PMC7443683          DOI: 10.1159/000504610

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  24 in total

Review 1.  Hemostatic resuscitation in postpartum hemorrhage - a supplement to surgery.

Authors:  Kim Ekelund; Gabriele Hanke; Jakob Stensballe; Anne Wikkelsøe; Charlotte Krebs Albrechtsen; Arash Afshari
Journal:  Acta Obstet Gynecol Scand       Date:  2015-03-05       Impact factor: 3.636

Review 2.  Circulating heparin-like anticoagulants: report of five consecutive cases and a review.

Authors:  A Tefferi; W L Nichols; E J Bowie
Journal:  Am J Med       Date:  1990-02       Impact factor: 4.965

3.  The contribution of the individual blood elements to the variability of thromboelastographic measures.

Authors:  Femke Noorman; John R Hess
Journal:  Transfusion       Date:  2018-09-20       Impact factor: 3.157

4.  Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy.

Authors:  Sisse R Ostrowski; Pär I Johansson
Journal:  J Trauma Acute Care Surg       Date:  2012-07       Impact factor: 3.313

5.  Isolation and characterization of glycosaminoglycans in human plasma.

Authors:  I Staprans; J M Felts
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

Review 6.  Thromboelastography and rotational thromboelastometry for the surgical intensivist: A narrative review.

Authors:  Byron C Drumheller; Deborah M Stein; Laura J Moore; Sandro B Rizoli; Mitchell J Cohen
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

7.  [Endogenous heparin-like syndrome: analysis of clinical observations].

Authors:  A Iu Bulanov; K V Iatskov; E M Shulutko; T E Glukhova; S A Andreĭchenko
Journal:  Anesteziol Reanimatol       Date:  2012 May-Jun

8.  Heparin elimination in patients with liver cirrhosis.

Authors:  A N Teien
Journal:  Thromb Haemost       Date:  1977-10-31       Impact factor: 5.249

9.  Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder.

Authors:  M S Khoory; M E Nesheim; E J Bowie; K G Mann
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

10.  Endogenous Heparinoids May Cause Bleeding in Mucor Infection and can be Detected by Nonactivated Thromboelastometry and Treated by Recombinant Activated Factor VII: A Case Report.

Authors:  Miroslav Durila; Petr Pavlicek; Ivana Hadacova; Jiri Nahlovsky; Daniela Janeckova
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more
  1 in total

1.  The conundrum of thrombosis with thrombocytopenia syndrome following COVID-19 vaccines.

Authors:  Nicholas G Kounis; Ioanna Koniari; Sophia N Kouni; Virginia Mplani; Panagiotis Plotas; Dimitrios Velissaris
Journal:  Am J Emerg Med       Date:  2022-04-21       Impact factor: 4.093

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.